혈전 제거 디바이스 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Thrombectomy Devices Market size is expected to reach USD 4.87 Billion in 2034 from USD 2.48 Billion (2025) growing at a CAGR of 7.79% during 2026-2034.

The Global Thrombectomy Devices Market is growing rapidly due to the increasing incidence of stroke and cardiovascular diseases worldwide. Thrombectomy devices are used to remove blood clots from arteries and restore normal blood flow, which is critical in emergency stroke treatment. Rising awareness about early stroke intervention and improved healthcare infrastructure are contributing to market growth.

Major drivers include advancements in minimally invasive surgical technologies and favorable reimbursement policies in several regions. Healthcare providers are increasingly adopting mechanical thrombectomy procedures due to their effectiveness and faster recovery times compared to traditional treatments. The aging population and lifestyle-related health conditions are further increasing the demand for advanced clot removal devices.

In the future, technological innovation is expected to enhance device precision and safety. Expanding healthcare access in developing countries will create new growth opportunities. Ongoing clinical research and training programs for specialists will further support adoption. With continued improvements in stroke management protocols, the thrombectomy devices market is set for sustained expansion globally.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

• Mechanical Thrombectomy
• Aspiration Thrombectomy
• Rheolytic Thrombectomy

By Type

• Automated Devices
• Manual Devices

By Utility

• Reusable Devices
• Disposable Devices

By Application

• Peripheral Diseases
• Coronary Disease
• Neural Diseases

COMPANIES PROFILED

• Johnson and Johnson, Koninklijke Philips NV, Boston Scientific Group, Medtronic plc, Terumo Corporation, Abbott Laboratories, AngioDynamics Inc, Penumbra Inc, Teleflex Incorporated, Stryker Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL THROMBECTOMY DEVICES MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Technology
• 4.2. Mechanical Thrombectomy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Aspiration Thrombectomy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Rheolytic Thrombectomy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL THROMBECTOMY DEVICES MARKET: BY TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Type
• 5.2. Automated Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Manual Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL THROMBECTOMY DEVICES MARKET: BY UTILITY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Utility
• 6.2. Reusable Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Disposable Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL THROMBECTOMY DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Peripheral Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Coronary Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Neural Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL THROMBECTOMY DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Technology
  • 8.2.2 By Type
  • 8.2.3 By Utility
  • 8.2.4 By Application
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Technology
  • 8.3.2 By Type
  • 8.3.3 By Utility
  • 8.3.4 By Application
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Technology
  • 8.4.2 By Type
  • 8.4.3 By Utility
  • 8.4.4 By Application
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Technology
  • 8.5.2 By Type
  • 8.5.3 By Utility
  • 8.5.4 By Application
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Technology
  • 8.6.2 By Type
  • 8.6.3 By Utility
  • 8.6.4 By Application
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL THROMBECTOMY DEVICES INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Johnson And Johnson
  • 10.2.2 Koninklijke Philips N.V
  • 10.2.3 Boston Scientific Group
  • 10.2.4 Medtronic Plc
  • 10.2.5 Terumo Corporation
  • 10.2.6 Abbott Laboratories
  • 10.2.7 AngioDynamics Inc
  • 10.2.8 Penumbra Inc
  • 10.2.9 Teleflex Incorporated
  • 10.2.10 Stryker Corporation